Showing 971-980 of 1090 results for "".
- Galimedix Therapeutics Presents Data for Investigational Eyedrops Containing GAL-101https://modernod.com/news/galimedix-therapeutics-presents-data-for-investigational-eyedrops-containing-gal-101/2476320/Galimedix Therapeutics, which is developing new solutions for ophthalmic and neurodegenerative diseases, presented an overview of data disclosed to date on its novel, first-in-class, investigational compound GAL-101, which in animal models caused sustained prevention of misfolded amyloid beta mol
- Federal Trade Commission Penalizes Online Sellers for Violating Contact Lens Rule, Bans Them from Selling Lenses in Futurehttps://modernod.com/news/federal-trade-commission-penalizes-online-sellers-for-violating-contact-lens-rule-bans-them-from-selling-lenses-in-future/2476152/The Healthcare Alliance for Patient Safety released a statement following yesterday’s announcement from the Federal Trade Commission (FTC)
- Optovue Showcases First OCT Angiography Metrics and Non-Contact Method for Corneal Measurements at Vision Expo Westhttps://modernod.com/news/optovue-showcases-worlds-first-oct-angiography-metrics-and-non-contact-method-for-corneal-measurements-at-vision-expo-west/2479832/Optovue showcased its AngioAnalytics platform, the world’s first OCT angiography (OCTA) blood vessel measurement technology to help clinicians manage diseases that cause progressive blindness, and 3D PAR, its 3-dimensional projection artifact removal software at Vision Expo West 2018. The
- SynergEyes and Brien Holden Vision Institute Join Forces for Specialty Contact Lens Developmenthttps://modernod.com/news/synergeyes-and-brien-holden-vision-institute-join-forces-for-specialty-contact-lens-development/2480098/SynergEyes announced a new partnership with the Brien Holden Vision Institute, a translational vision correction center that delivers advanced, customized vision correction for myopes and presbyopes. The exclusive worldwide licensing agreement will enable the manufacturing of design technologies
- Johnson & Johnson Vision Presents New Data on Silicone Hydrogel Contact Lens Muco-Adhesive Propertieshttps://modernod.com/news/johnson-johnson-vision-presents-new-data-on-silicone-hydrogel-contact-lens-muco-adhesive-properties/2480192/Johnson & Johnson Vision presented new data at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting in Honolulu, Hawaii. The data measured how the extent of crosslinking affects muco-adhesion in a laboratory study with corneal epithel
- J&J to Present New Data Demonstrating Superiority of Acuvue Oasys Max 1-Day for Astigmatism at AAOpthttps://modernod.com/news/jj-to-present-new-data-demonstrating-superiority-of-acuvue-oasys-max-1-day-for-astigmatism-at-aaopt/2484158/Johnson & Johnson announced new clinical data demonstrating significantly higher end-of-day comfort and stronger overall patient preference for the Acuvue Oasys Max 1-Day for Astigmatism contact lenses compared to Dailies Total1 for Astigmatism.
- Roche Receives CE Mark for Contivue Port Delivery Platform with Susvimo in Wet AMDhttps://modernod.com/news/roche-receives-ce-mark-for-contivue-port-delivery-platform-with-susvimo-in-wet-amd/2484134/The European Union (EU) has granted CE mark for Roche's Port Delivery Platform containing Susvimo, which will be branded as Contivue in the EU. Contivue provides sustained ocular drug delivery for patients living with wet age-related macular
- EMA Review Finds Rare Risk of Vision Loss Associated With Semaglutide Medicineshttps://modernod.com/news/ema-review-finds-rare-risk-of-vision-loss-associated-with-semaglutide-medicines/2482842/The European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has concluded its review of semaglutide-containing medicines following concerns about a potential increased risk of non-arteritic anterior ischemic optic neuropathy (NAIO
- Bausch + Lomb Launches Blink Nourish and Blink Boost Lubricating Eye Drops in the UShttps://modernod.com/news/bausch-lomb-launches-blink-nourish-and-blink-boost-lubricating-eye-drops-in-the-us/2482834/Bausch + Lomb announced the US launch of Blink Nourish and Blink Boost lubricating eye drops. According to B+L, both products are preservative-free, contact-lens friendly and uniquely formulated to provide hydration and comfort for dry e
- Bausch + Lomb Launches Zenlens CHROMA HOA in the UShttps://modernod.com/news/bausch-lomb-launches-zenlens-chroma-hoa-in-the-us/2482802/Bausch + Lomb announced the US launch of Zenlens CHROMA HOA scleral contact lenses. Designed to correct advanced higher-order aberrations (HOA), this custom, wavefront-guided scleral lens technology delivers enhanced vision and improves clarity by reducing symptoms such as halos an